Leerink Partners Raises Price Target on Insulet (PODD) Following 2Q15 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Insulet Reports Second Quarter 2015 Financial Results
August 12, 2015 4:01 PM EDTBILLERICA, Mass., Aug. 12, 2015 /PRNewswire/ -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced financial results for the three months ended June 30, 2015.       Â
Second Quarter Highlights and Recent Developments:
Second quarter financial results: Total revenue of $75.6 million exceeds Company's prior expectations of $67 to $70 million. U.S. OmniPod revenue of $44.7 million. International OmniPod revenue of $7.7 million. Drug Delivery revenue of $7.5 million. Neighborhood Diabetes revenue of $15.7 million. Announced today appointment of Michael... More